Spectral Tissue Recognition for Breast Cancer Surgery

This study tests a new imaging tool that helps surgeons see if any cancer cells are left behind during a lumpectomy. It may reduce the need for a second surgery.

This trial tests a new method using tiny particles that glow when they find cancer cells on the edges of removed breast tissue and in lymph nodes. The goal is to help surgeons see if any cancer is left behind during the same surgery, so they can remove it right away.

This study compares two ways surgeons take “margin” samples (tissue from the edge of the tumor area) during breast-conserving surgery for early breast cancer. It uses a guidance device to help collect these samples and aims to see which approach better supports safe, effective treatment.

This trial tests a microscope-like scanner that helps surgeons see if all cancer cells have been removed during breast-conserving surgery. It may reduce the need for a second surgery by checking the removed tissue immediately.

This study looks at proteins and imaging patterns (from tissue, fluid near the tumor, and blood) to better understand breast cancer markers. It may help researchers find clues that doctors can use to evaluate breast nodules and newly diagnosed invasive breast cancer.

This study tests a new imaging tool that helps surgeons see cancer margins in real time during a lumpectomy, aiming to reduce the need for a second surgery. It is for women with early-stage breast cancer who are planning a lumpectomy.